A Pivotal Pharmacokinetic Bioequivalence Study Comparing Generic to Reference Liposome-Encapsulated Doxorubicin Hydrochloride in Subjects with Epithelial Ovarian Carcinoma Who Have Failed Platinum-Based Chemotherapy - Regional Cancer Care Associates LLC

Clinical Trials

A Pivotal Pharmacokinetic Bioequivalence Study Comparing Generic to Reference Liposome-Encapsulated Doxorubicin Hydrochloride in Subjects with Epithelial Ovarian Carcinoma Who Have Failed Platinum-Based Chemotherapy

Type of Cancer
Ovarian Cancer
Locations
Bethesda
Sponsor
Tolmar
Protocol Number
TOL2649G
Cancer Diagnosis
To Learn More Call
201-510-0910